UNITY BIOTECHNOLOGY INC's ticker is and the CUSIP is 91381U200. A total of 55 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $159 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 491,751 | $134,731 | 7.85% |
| ARCH Venture Management, LLC | 1,004,817 | $2,753,199 | 0.70% |
| 683 Capital Management, LLC | 240,000 | $657,600 | 0.06% |
| Parkman Healthcare Partners LLC | 42,749 | $117,132 | 0.03% |
| CVI Holdings, LLC | 74,100 | $203,034 | 0.03% |
| Alyeska Investment Group, L.P. | 697,448 | $1,911,008 | 0.02% |
| Arete Wealth Advisors, LLC | 10,392 | $140,582,970 | 0.01% |
| Virtu Financial LLC | 20,155 | $55 | 0.01% |
| Johnson Midwest Financial, LLC | 661 | $2 | 0.01% |
| Cercano Management LLC | 41,238 | $112,992 | 0.01% |